These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25148033)

  • 1. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
    PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes correlated with early-stage bladder cancer progression.
    Stone R; Sabichi AL; Gill J; Lee IL; Adegboyega P; Dai MS; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
    Cancer Prev Res (Phila); 2010 Jun; 3(6):776-86. PubMed ID: 20501863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.
    Conconi D; Panzeri E; Redaelli S; Bovo G; Volante M; Viganò P; Strada G; Dalprà L; Bentivegna A
    BMC Res Notes; 2012 Oct; 5():607. PubMed ID: 23114535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
    Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
    Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
    Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
    Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Ephb2 and Ephb4 in breast carcinoma.
    Wu Q; Suo Z; Risberg B; Karlsson MG; Villman K; Nesland JM
    Pathol Oncol Res; 2004; 10(1):26-33. PubMed ID: 15029258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
    Lee TH; Heo JH; Jeong JY; Lee GH; Park DS; Kim TH
    Yonsei Med J; 2021 Aug; 62(8):679-690. PubMed ID: 34296545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.
    Patschan O; Shariat SF; Chade DC; Karakiewicz PI; Ashfaq R; Lotan Y; Hotakainen K; Stenman UH; Bjartell A
    World J Urol; 2012 Dec; 30(6):785-94. PubMed ID: 21739120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
    Xia G; Kumar SR; Stein JP; Singh J; Krasnoperov V; Zhu S; Hassanieh L; Smith DL; Buscarini M; Broek D; Quinn DI; Weaver FA; Gill PS
    Oncogene; 2006 Feb; 25(5):769-80. PubMed ID: 16205642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.
    Ozgür E; Heidenreich A; Dagtekin O; Engelmann U; Bloch W
    Urol Oncol; 2011; 29(1):78-84. PubMed ID: 19272799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.
    Sun W; Zhang PL; Herrera GA
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):327-31. PubMed ID: 12607601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphB4 as a therapeutic target in mesothelioma.
    Liu R; Ferguson BD; Zhou Y; Naga K; Salgia R; Gill PS; Krasnoperov V
    BMC Cancer; 2013 May; 13():269. PubMed ID: 23721559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
    Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
    Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS; Lee JH; Yu HS; Choi YD
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.